Jama-Journal of the American Medical Association最新文献

筛选
英文 中文
Prostate Cancer: A Review. 前列腺癌:综述。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0228
Ruben Raychaudhuri, Daniel W Lin, R Bruce Montgomery
{"title":"Prostate Cancer: A Review.","authors":"Ruben Raychaudhuri, Daniel W Lin, R Bruce Montgomery","doi":"10.1001/jama.2025.0228","DOIUrl":"10.1001/jama.2025.0228","url":null,"abstract":"<p><strong>Importance: </strong>Prostate cancer is the most common nonskin cancer in men in the US, with an estimated 299 010 new cases and 35 250 deaths in 2024. Prostate cancer is the second most common cancer in men worldwide, with 1 466 680 new cases and 396 792 deaths in 2022.</p><p><strong>Observations: </strong>The most common type of prostate cancer is adenocarcinoma (≥99%), and the median age at diagnosis is 67 years. More than 50% of prostate cancer risk is attributable to genetic factors; older age and Black race (annual incidence rate, 173.0 cases per 100 000 Black men vs 97.1 cases per 100 000 White men) are also strong risk factors. Recent guidelines encourage shared decision-making for prostate-specific antigen (PSA) screening. At diagnosis, approximately 75% of patients have cancer localized to the prostate, which is associated with a 5-year survival rate of nearly 100%. Based on risk stratification that incorporates life expectancy, tumor grade (Gleason score), tumor size, and PSA level, one-third of patients with localized prostate cancer are appropriate for active surveillance with serial PSA measurements, prostate biopsies, or magnetic resonance imaging, and initiation of treatment if the Gleason score or tumor stage increases. For patients with higher-risk disease, radiation therapy or radical prostatectomy are reasonable options; treatment decision-making should include consideration of adverse events and comorbidities. Despite definitive therapy, 2% to 56% of men with localized disease develop distant metastases, depending on tumor risk factors. At presentation, approximately 14% of patients have metastases to regional lymph nodes. An additional 10% of men have distant metastases that are associated with a 5-year survival rate of 37%. Treatment of metastatic prostate cancer primarily relies on androgen deprivation therapy, most commonly through medical castration with gonadotropin-releasing hormone agonists. For patients with newly diagnosed metastatic prostate cancer, the addition of androgen receptor pathway inhibitors (eg, darolutamide, abiraterone) improves survival. Use of abiraterone improved the median overall survival from 36.5 months to 53.3 months (hazard ratio, 0.66 [95% CI, 0.56-0.78]) compared with medical castration alone. Chemotherapy (docetaxel) may be considered, especially for patients with more extensive disease.</p><p><strong>Conclusions and relevance: </strong>Approximately 1.5 million new cases of prostate cancer are diagnosed annually worldwide. Approximately 75% of patients present with cancer localized to the prostate, which is associated with a 5-year survival rate of nearly 100%. Management includes active surveillance, prostatectomy, or radiation therapy, depending on risk of progression. Approximately 10% of patients present with metastatic prostate cancer, which has a 5-year survival rate of 37%. First-line therapies for metastatic prostate cancer include androgen deprivation and novel androgen","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1433-1446"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143588311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Blood Test Shows Promise in Detecting Pancreatic Cancer. 新的血液检测有望检测胰腺癌。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2572
Samantha Anderer
{"title":"New Blood Test Shows Promise in Detecting Pancreatic Cancer.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2572","DOIUrl":"10.1001/jama.2025.2572","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1385"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein S Genomics and Proteomics Refine Thrombosis Risk. 蛋白质S基因组学和蛋白质组学可改善血栓形成风险。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.1883
Margaret V Ragni
{"title":"Protein S Genomics and Proteomics Refine Thrombosis Risk.","authors":"Margaret V Ragni","doi":"10.1001/jama.2025.1883","DOIUrl":"10.1001/jama.2025.1883","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1401-1402"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulse Oximetry and Skin Pigmentation-New Guidance From the FDA. 脉搏血氧仪和皮肤色素——FDA的新指南。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.1959
Michael S Lipnick, Odinakachukwu Ehie, Elizabeth N Igaga, Philip Bicker
{"title":"Pulse Oximetry and Skin Pigmentation-New Guidance From the FDA.","authors":"Michael S Lipnick, Odinakachukwu Ehie, Elizabeth N Igaga, Philip Bicker","doi":"10.1001/jama.2025.1959","DOIUrl":"10.1001/jama.2025.1959","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1393-1395"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How AI Could Improve Health Care for People With Intellectual and Developmental Disabilities. 人工智能如何改善智力和发育障碍者的医疗保健。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2552
Yulin Hswen, Nora Collins
{"title":"How AI Could Improve Health Care for People With Intellectual and Developmental Disabilities.","authors":"Yulin Hswen, Nora Collins","doi":"10.1001/jama.2025.2552","DOIUrl":"10.1001/jama.2025.2552","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1377-1379"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
US Drug Overdose Deaths Declined in 2023. 2023年美国药物过量死亡人数下降。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2570
Samantha Anderer
{"title":"US Drug Overdose Deaths Declined in 2023.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2570","DOIUrl":"10.1001/jama.2025.2570","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1385"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Panel Advises Against Common Spine Treatments for Chronic Back Pain. 专家小组建议不要使用常见的脊椎治疗慢性背痛。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2575
Samantha Anderer
{"title":"Expert Panel Advises Against Common Spine Treatments for Chronic Back Pain.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2575","DOIUrl":"10.1001/jama.2025.2575","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1386"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143733269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transforming the Cardiovascular Disease Prevention Paradigm: See Disease, Treat Disease. 转变心血管疾病预防模式:见病治病。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2323
Khurram Nasir, Ron Blankstein
{"title":"Transforming the Cardiovascular Disease Prevention Paradigm: See Disease, Treat Disease.","authors":"Khurram Nasir, Ron Blankstein","doi":"10.1001/jama.2025.2323","DOIUrl":"10.1001/jama.2025.2323","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1398-1400"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gap Years. 年的差距。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.0165
Elias Lugo-Fagundo, Charles K Crawford, Elliot K Fishman
{"title":"Gap Years.","authors":"Elias Lugo-Fagundo, Charles K Crawford, Elliot K Fishman","doi":"10.1001/jama.2025.0165","DOIUrl":"10.1001/jama.2025.0165","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1459"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some Hormonal Birth Control Tied to Greater Risk of Heart Attack and Stroke. 一些激素避孕措施与心脏病发作和中风风险增加有关。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2025-04-22 DOI: 10.1001/jama.2025.2571
Samantha Anderer
{"title":"Some Hormonal Birth Control Tied to Greater Risk of Heart Attack and Stroke.","authors":"Samantha Anderer","doi":"10.1001/jama.2025.2571","DOIUrl":"10.1001/jama.2025.2571","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1385"},"PeriodicalIF":63.1,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信